1
|
Anwer KE, Hamza ZK, Ramadan RM. Synthesis, spectroscopic, DFT calculations, biological activity, SAR, and molecular docking studies of novel bioactive pyridine derivatives. Sci Rep 2023; 13:15598. [PMID: 37730837 PMCID: PMC10511440 DOI: 10.1038/s41598-023-42714-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Accepted: 09/13/2023] [Indexed: 09/22/2023] Open
Abstract
Enaminonitrile pyridine derivative was used as a precursor for preparation of fourteen heterocyclic compounds using both conventional thermal and microwave techniques. Diverse organic reagents, such as chloroacetyl chloride, acetic anhydride, chloroacetic acid, carbon disulfide, p-toluene sulfonyl chloride, maleic anhydride, phthalic anhydride, were used. The chemical formulae and structures of isolated derivatives were obtained using different analytical and spectroscopic techniques such as IR, 1H-, 13C-NMR as well as mass spectrometry. The spectroscopic analyses revealed diverse structure arrangements for the products. Molecular structure optimization of certain compounds were performed by the density functional theory (DFT/B3LYP) method and the basis set 6-31 G with double zeta plus polarization (d,p). The antimicrobial inhibition and the antioxidant activity of the reported compounds were screened. Compounds 5, 6, 11 and 13 exhibited the highest antibacterial inhibition, while compound 8 gave the highest scavenging activity (IC50 43.39 µg/ml) against the DPPH radical. Structure-activity relationship of the reported compounds were correlated with the data of antibacterial and the antioxidant activity. The global reactivity descriptors were also correlated with the biological properties of compounds. The molecular docking studies of reported compounds were investigated, and the analysis showed that the docked compounds have highly negative values for the functional binding scores. The binding interaction was found to be correlated with the substituent fragments of the compounds.
Collapse
Affiliation(s)
- Kurls E Anwer
- Department of Chemistry, Faculty of Science, Ain Shams University, Cairo, Egypt
| | - Zeinab K Hamza
- Food Toxicology and Contaminants Department, National Research Centre, Giza, Egypt
| | - Ramadan M Ramadan
- Department of Chemistry, Faculty of Science, Ain Shams University, Cairo, Egypt.
| |
Collapse
|
2
|
Yousefi M, Rad MS, Shakibazadeh R, Ghodrati L, Kachoie MA. Simulating a heteroatomic CBN fullerene-like nanocage towards the drug delivery of fluorouracil. MOLECULAR SIMULATION 2022. [DOI: 10.1080/08927022.2022.2086252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Mohammad Yousefi
- Department of Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
| | - Mehdi Salehi Rad
- Department of Chemistry, Yadegar-e Imam Khomeini (RAH) Shahr-e-Rey Branch, Islamic Azad University, Tehran, Iran
| | | | - Leila Ghodrati
- Department of Medicinal Plants, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
| | - Mehrdad Ataie Kachoie
- Department of Medicinal Plants, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
- Medicinal Plants Processing Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
| |
Collapse
|
3
|
Chen S, Ouyang H, He D, Liu D, Wang X, Chen H, Pan W, Li Q, Xie W, Yu C. Functionalized PAMAM-Based Nanoformulation for Targeted Delivery of 5-Fluorouracil in Hepatocellular Carcinoma. Curr Pharm Des 2022; 28:2113-2125. [PMID: 35524673 DOI: 10.2174/1381612828666220506111918] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 03/18/2022] [Indexed: 12/24/2022]
Abstract
BACKGROUND Efficacy of a traditional anticancer drug is challenged by adverse effects of the drug including its nonspecific bio-distribution, short half-life and side effects. Dendrimer-based targeted drug delivery sysytem has been considered as a promising strategy to increase targeting ability and reduce adverse effects of anti-cancer drugs. OBJECTIVE This study analyzed the feasibility whether the anticancer drug 5-fluorouracil (5-FU) could be delivered by functionalized fifth-poly(amidoamine) (PAMAM) with the peptide WP05 and the acetic anhydride to the liver cancer cells, reducing toxicity of the PAMAM and improving the targeting property of 5-FU during delivery. METHODS The functionalized PAMAM-based nanoformulation (WP05-G5.0NHAC-FUA) was fabricated through an amide condensation reaction to improve therapeutic efficacy of 5-Fluorouracil (5-FU) in hepatocellular carcinoma (HCC). The physicochemical structure, particle size, zeta potential, stability and in vitro release characteristics of WP05-G5.0NHAC-FUA were evaluated. In addition, the targeting, biocompatibility, anti-proliferation and anti-migration of WP05-G5.0NHAC-FUA were investigated. The anti-tumor effect of WP05-G5.0NHAC-FUA in vivo was evaluated by constructing xenograft tumor models of hunman hepatoma cells (Bel-7402) implanted in nude mice. RESULTS The resultant WP05-G5.0NHAC-FUA displayed spherical-like nanoparticles with the size of 174.20 ± 3.59 nm. Zeta potential and the drug loading of WP05-G5.0NHAC-FUA were 5.62 ± 0.41mV and 28.67 ± 1.25 %, respectively. Notably, the optimized 5-FU-loaded formulation showed greater cytotoxicity with an IC50 of 30.80 ±4.04 μg/mL than free 5-FU (114.93 ±1.43 μg/mL) in Bel-7402 cancer liver cells, but a significantly reduced side effect relative to free 5-FU in L02 normal liver cells. In vivo animal study further confirmed efficient tumor accumulation and enhanced therapeutic efficiency. CONCLUSION The developed nanoformulation is a promising platform for the targeting delivery of 5-FU and provides a promising solution for improving the efficacy of hepatocellular carcinoma chemotherapy.
Collapse
Affiliation(s)
- Siwei Chen
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China.,Provincial Key Laboratory of tumor microenvironment responsive drug research,28 Western Changshen Road, Hengyang, Hunan, China
| | - Hu Ouyang
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Dongxiu He
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China.,Provincial Key Laboratory of tumor microenvironment responsive drug research,28 Western Changshen Road, Hengyang, Hunan, China
| | - Daquan Liu
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Xiao Wang
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Hongyuan Chen
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Wei Pan
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Qi Li
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Weiquan Xie
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China
| | - Cuiyun Yu
- Institute of Pharmacy & Pharmacology, Universityof South China, Hengyang, Hunan, China.,Provincial Key Laboratory of tumor microenvironment responsive drug research,28 Western Changshen Road, Hengyang, Hunan, China
| |
Collapse
|
4
|
Szczęch M, Hinz A, Łopuszyńska N, Bzowska M, Węglarz WP, Szczepanowicz K. Polyaminoacid Based Core@shell Nanocarriers of 5-Fluorouracil: Synthesis, Properties and Theranostics Application. Int J Mol Sci 2021; 22:ijms222312762. [PMID: 34884566 PMCID: PMC8657732 DOI: 10.3390/ijms222312762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 11/22/2021] [Accepted: 11/23/2021] [Indexed: 11/30/2022] Open
Abstract
Cancer is one of the most important health problems of our population, and one of the common anticancer treatments is chemotherapy. The disadvantages of chemotherapy are related to the drug’s toxic effects, which act on cancer cells and the healthy part of the body. The solution of the problem is drug encapsulation and drug targeting. The present study aimed to develop a novel method of preparing multifunctional 5-Fluorouracil (5-FU) nanocarriers and their in vitro characterization. 5-FU polyaminoacid-based core@shell nanocarriers were formed by encapsulation drug-loaded nanocores with polyaminoacids multilayer shell via layer-by-layer method. The size of prepared nanocarriers ranged between 80–200 nm. Biocompatibility of our nanocarriers as well as activity of the encapsulated drug were confirmed by MTT tests. Moreover, the ability to the real-time observation of developed nanocarriers and drug accumulation inside the target was confirmed by fluorine magnetic resonance imaging (19F-MRI).
Collapse
Affiliation(s)
- Marta Szczęch
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland;
| | - Alicja Hinz
- Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; (A.H.); (M.B.)
| | - Natalia Łopuszyńska
- Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland; (N.Ł.); (W.P.W.)
| | - Monika Bzowska
- Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; (A.H.); (M.B.)
| | - Władysław P. Węglarz
- Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland; (N.Ł.); (W.P.W.)
| | - Krzysztof Szczepanowicz
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland;
- Correspondence:
| |
Collapse
|
5
|
Atashi F, Vahed N, Emamverdizadeh P, Fattahi S, Paya L. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review. J Dent Res Dent Clin Dent Prospects 2021; 15:219-225. [PMID: 34712414 PMCID: PMC8538146 DOI: 10.34172/joddd.2021.036] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2021] [Accepted: 06/09/2021] [Indexed: 12/25/2022] Open
Abstract
Head and neck cancers are highly prevalent worldwide. Most of these lesions are diagnosed in the advanced stages of the disease. Thus, they do not often have a good long-term prognosis. Like other cancer types, head and neck cancers are managed by surgery, radiotherapy, and chemotherapy. Despite significant advances in the treatment of oral squamous cell carcinoma (OSCC), physicians encounter several challenges in the course of treatment. Various mechanisms mediate the clinical responses of a certain cancer to medications. Thus, efficient treatment planning requires adequate knowledge about the genes involved in drug resistance and the evaluation of the frequency percentage of resistance. Several studies have evaluated the causes and frequency percentages of 5-fluorouracil (5-FU) and cisplatin resistance. In this systematic review, all the relevant articles published until November 30, 2019, were retrieved from the Scopus, Embase, Medline, ISI, Web of Science, and Cochrane databases using certain MeSH and EMTTree keywords. A total of 2164 articles were retrieved of which, 18 were included in the review since they had reported the frequency percentages of drug resistance. Of all, 10 articles had evaluated cisplatin (1317 samples). A meta-analysis of the results revealed a frequency of 33% for cisplatin resistance. Eight studies had evaluated 5-FU (476 samples). A meta-analysis of the results revealed a frequency of 40.2 % for 5-FU resistance. Overcoming cisplatin resistance or 5-FU resistance can significantly enhance recovery in advanced HNSCC. Attempts should be made to eliminate the cause and use multi-drug regimens to increase the success rate of treatment.
Collapse
Affiliation(s)
| | - Nafiseh Vahed
- Research Center for Evidence-based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Parya Emamverdizadeh
- Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Shirin Fattahi
- Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Ladan Paya
- Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|
6
|
Nabih S, Hassn SS. Nonchemical integration of Au/Ag-based reduced graphene nanohybrid combined with 5-Fluorouracil drug to treat cancer cells. Life Sci 2021; 272:119262. [PMID: 33639151 DOI: 10.1016/j.lfs.2021.119262] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Revised: 02/07/2021] [Accepted: 02/18/2021] [Indexed: 10/22/2022]
Abstract
The perpetual lack of advanced strategies to prevent aggressive breast cancer with multiple categories represents challenging scientific society problems. Reduced graphene oxide- can treat disease, which was recently investigated due to its ability to induce apoptosis-based death. This research tested the chemotherapeutics in vitro efficacy of reduced graphene oxide embedded with gold and silver nanoparticles toward drug-sensitive breast cancer cells (MCF-7) and their cytotoxicity. Synthesis of the Au-Ag/rGO-5FU nanocomposites has been conducted using a wet chemical approach with chitosan aid as a pore directing and capping agent. The particle structure and morphology well characterized using different systems. HR-TEM shows a narrow-sized distribution of less than 100 nm, which is proper for cell membranes and medical use. The physical combination of the nanocomposite and 5-FU drug has been conducted mechanically using wet chemistry. The Au/Ag/rGO-5FU material's high activity enables it to produce reactive oxygen radicals, which display a potential against MCF-7 cell lines. All the results, including those obtained via cytometry, use the combination of Au/Ag/rGO-5FU to show a more substantial anticancer influence and more drug stability than pure 5-FU.
Collapse
Affiliation(s)
- Shimaa Nabih
- Basic Science Departments, Modern Academy for Engineering and Technology, Maadi, Egypt.
| | - Shaymaa Sherif Hassn
- Basic Science Departments, Modern Academy for Engineering and Technology, Maadi, Egypt
| |
Collapse
|
7
|
Abstract
Lung cancer is one of the serious malignant tumors with high morbidity and mortality due to the poor diagnosis and early metastasis. The developing nanotechnology provides novel concepts and research strategies for the lung cancer diagnosis by employing nanomaterials as diagnostic reagents to enhance diagnostic efficiency. This commentary introduces recent progress using nanoparticles for lung cancer diagnosis from two aspects of in vivo and in vitro detection. The challenges and future research perspectives are proposed at the end of the paper.
Collapse
|
8
|
Zhang Y, Zeng B, Liu Y, Li P, Chen L, Zhao J. A Penta‐Eu
III
Sandwiched Dawson Selenotungstate and Its Unique Luminescence Properties. Eur J Inorg Chem 2020. [DOI: 10.1002/ejic.202000519] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Yan Zhang
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| | - Baoxing Zeng
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| | - Yifan Liu
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| | - Pan Li
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| | - Lijuan Chen
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| | - Junwei Zhao
- Henan Key Laboratory of Polyoxometalate Chemistry College of Chemistry and Chemical Engineering Henan University 475004 Kaifeng Henan P. R. China
| |
Collapse
|